WASHINGTON, DC – Yesterday, President Trump’s opioid commission released their final report, complete with more than 50 recommendations detailing how to respond to the opioid crisis. The report also touched on fentanyl, a synthetic opioid that is 50 times more powerful than heroin and 100 times more powerful than morphine. It is also the leading cause of opioid overdose deaths.
It marks another important step in the collective effort to combat the crisis, particularly following last week’s declaration of a public health emergency.
Energy and Commerce has been – and continues to be – at the tip of the spear in the national fight to combat the opioid crisis. From the earliest days of our past and ongoing investigations to present day, our members have been committed to pressing officials on how this scourge evolved, and what legislative solutions can be pursued.
As Energy and Commerce Committee Chairman Greg Walden (R-OR) and #SubHealth Chairman Michael C. Burgess, M.D. (R-TX) said following the public health emergency declaration last week, “We stand ready to work with the administration to deliver relief for the tens-of-thousands of Americans suffering from this epidemic on a daily basis.”
Click HERE to read a copy of the commission’s report.
Click HERE to learn about the committee’s past and ongoing efforts to combat the opioid crisis.
U.S. Must Do More to Combat Opioid Abuse, Panel Says
The federal government should set up drug courts across the country, retrain medical prescribers on opioid use and reduce incentives for doctors to offer the powerful painkillers, a high-profile presidential commission on opioids said Wednesday.
The proposals were among 56 recommendations from the President’s Commission on Combating Drug Addiction and the Opioid Crisis, headed by New Jersey Gov. Chris Christie, a former rival of President Donald Trump for the Republican presidential nomination.
The commission also said the government should increase its oversight of large employers’ health plans and their compliance with requirements to treat substance abuse as they would other illnesses. It said the Education Department should work with states to upgrade schools’ drug abuse programs, and that the federal government should engage with states to expand access to naloxone, an overdose-reversal drug.
The commission said questions about pain should be removed from federal patient satisfaction surveys for physicians and hospitals “so that providers are never incentivized for offering opioids to raise their survey score.” …
At a commission meeting Wednesday as the report was released, Mr. Christie said he favored efforts by state and federal regulators to take a tougher approach to insurers who refuse to cover treatment.
Other commission recommendations included an increase in federal sentencing penalties for the trafficking of fentanyl and fentanyl analogues, and action by Washington to help shape the information that patients must be given before they receive an opioid prescription for chronic pain.
Read the full article online HERE.